Deciphering the role of post-translational modifications in fanconi anemia proteins and their influence on tumorigenesis.
Autor: | Ma R; State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei, 430062, China., Xu X; State Key Laboratory of Biocatalysis and Enzyme Engineering, School of Life Sciences, Hubei University, Wuhan, Hubei, 430062, China. xinlin@hubu.edu.cn. |
---|---|
Jazyk: | angličtina |
Zdroj: | Cancer gene therapy [Cancer Gene Ther] 2024 Aug; Vol. 31 (8), pp. 1113-1123. Date of Electronic Publication: 2024 Jun 15. |
DOI: | 10.1038/s41417-024-00797-1 |
Abstrakt: | Fanconi anemia (FA) is an autosomal or X-linked human disease, characterized by bone marrow failure, cancer susceptibility and various developmental abnormalities. So far, at least 22 FA genes (FANCA-W) have been identified. Germline inactivation of any one of these FA genes causes FA symptoms. Proteins encoded by FA genes are involved in the Fanconi anemia pathway, which is known for its roles in DNA inter-strand crosslinks (ICLs) repair. Besides, its roles in genome maintenance upon replication stress has also been reported. Post-translational modifications (PTMs) of FA proteins, particularly phosphorylation and ubiquitination, emerge as critical determinants in the activation of the FA pathway during ICL repair or replication stress response. Consequent inactivation of the FA pathway engenders heightened chromosomal instability, thereby constituting a genetic susceptibility conducive to cancer predisposition and the exacerbation of tumorigenesis. In this review, we have combined recent structural analysis of FA proteins and summarized knowledge on the functions of different PTMs in regulating FA pathways, and discuss potential contributions stemming from mutations at PTMs to the genesis and progression of tumorigenesis. (© 2024. The Author(s), under exclusive licence to Springer Nature America, Inc.) |
Databáze: | MEDLINE |
Externí odkaz: |